Monday, June 27, 2011

Daily News Digest: Reuters Health News Headlines - Yahoo! News

Daily News Alert
Yahoo! Alerts Yahoo! News | My Alerts | Edit Alert
Monday, June 27, 2011 12:06 AM PDT
Today's Reuters Health News Headlines - Yahoo! News:
Ban fast food ads on TV: U.S. doctors
Sun,26 Jun 2011 10:43 PM PDT
Reuters - NEW YORK (Reuters Health) - Fast food ads on TV are making American youth fatter and should be banned in children's programming, an influential group of doctors said Monday. Full Story1
Top

Halozyme keeps options open for ultrafast insulin
Sun,26 Jun 2011 02:30 PM PDT
Reuters - SAN DIEGO (Reuters) - Halozyme Therapeutics Inc, which specializes in reformulating drug products available only as infusions, expects to have key results this fall from trials of its "ultrafast" insulin formulations. Full Story1
Top

"Lean gene" ups risk of heart disease and diabetes
Sun,26 Jun 2011 10:07 AM PDT
Reuters - LONDON (Reuters) - Being slim may not always lead to a lower risk of heart disease and diabetes, scientists said Sunday after they identified a gene linked both to having a lean body and to a higher risk of metabolic diseases. Full Story1
Top

Cream may buy time for snake bite victims
Sun,26 Jun 2011 10:04 AM PDT
Reuters - HONG KONG, Jun (Reuters) - A chemical compound that is used on heart patients may raise chances of survival for snakebite victims, Australian scientists said on Monday. Full Story1
Top

AIDS drugs can cause premature ageing: study
Sun,26 Jun 2011 10:04 AM PDT
Reuters -

photoLONDON (Reuters) - A class of generic AIDS drugs often used to treat HIV in Africa and other poor regions can cause premature aging and lead to age-related illnesses such as heart disease and dementia, scientists said on Sunday.


Full Story1
Top

Roche to fight for Avastin as breast cancer drug
Sun,26 Jun 2011 09:18 AM PDT
Reuters -

photoWASHINGTON (Reuters) -- Drugmaker Roche Holding AG will try to convince U.S. regulators to reverse course on Avastin, the world's best-selling cancer medicine, and approve its use for breast cancer in a hearing this week.


Full Story1
Top

Chronology: Key dates for Roche cancer drug Avastin
Sun,26 Jun 2011 09:18 AM PDT
Reuters - WASHINGTON (Reuters) - Roche unit Genentech is appealing a U.S. proposal to withdraw breast cancer as an approved use for Avastin, the world's best-selling cancer drug with $6 billion in annual sales. A hearing on the appeal takes place Tuesday and Wednesday. Full Story1
Top

France should pay if E.coli warning wrong: British MEP
Sun,26 Jun 2011 07:51 AM PDT
Reuters - BORDEAUX, France (Reuters) - A British MEP called on France to pay compensation if a British company linked by the French government to an E.coli outbreak in Bordeaux turned out not to be responsible. Full Story1
Top

Bristol diabetes pill tied to certain cancers
Sat,25 Jun 2011 02:34 PM PDT
Reuters -

photoSAN DIEGO (Reuters) - A new type of diabetes pill being developed by Bristol-Myers Squibb and AstraZeneca was effective in a two-year study but more bladder and breast cancers have been found in patients treated with the drug.


Full Story1
Top

France bans UK garden firm's seeds in E.coli scare
Sat,25 Jun 2011 09:01 AM PDT
Reuters -

photoPARIS (Reuters) - At least two people suffering from E.coli in the French city of Bordeaux have the strain that caused scores of deaths in Germany, French authorities said, and they halted sales of vegetable seeds from a British gardening firm.


Full Story1
Top

Global diabetes epidemic balloons to 350 million
Sat,25 Jun 2011 08:34 AM PDT
Reuters -

photoLONDON/SAN DIEGO (Reuters) - The number of adults with diabetes worldwide has more than doubled since 1980 to 347 million, a far larger number than previously thought and one that suggests costs of treating the disease will also balloon.


Full Story1
Top

Novo Nordisk says degludec insulin outperforms Sanofi rival
Fri,24 Jun 2011 05:00 PM PDT
Reuters - COPENHAGEN (Reuters) - Studies showed Novo Nordisk's insulin degludec lowered blood sugar levels with significantly reduced rates of hypoglycaemia when compared with rival Sanofi's Lantus, the Danish firm said on Saturday. Full Story1
Top

Amylin study shows insignificant heart rhythm link
Fri,24 Jun 2011 04:29 PM PDT
Reuters - SAN DIEGO (Reuters) - Analysis of an earlier trial found a "clinically insignificant" link between changes in heart rhythms and use of Bydureon, a long-acting diabetes drug being developed by Amylin Pharmaceuticals, Eli Lilly and Alkermes. Full Story1
Top

FDA rejects Pain, Pfizer anti-abuse painkiller
Fri,24 Jun 2011 03:46 PM PDT
Reuters - BANGALORE (Reuters) - Pfizer Inc and Pain Therapeutics Inc said U.S. health regulators declined to approve their abuse-resistant painkiller Remoxy, less than a week after a similar Pfizer drug was cleared for sale, sending Pain's stock crashing Friday. Full Story1
Top

Abbott says blood sugar monitoring devices stolen
Fri,24 Jun 2011 02:45 PM PDT
Reuters - (Reuters) - Abbott Laboratories said it was working with authorities to retrieve one tractor-trailer shipment of blood glucose monitoring products that was reported stolen on June 19. Full Story1
Top



You received this email because you subscribed to Yahoo! Alerts. Use this link to unsubscribe from this alert. To change your communications preferences for other Yahoo! business lines, please visit your Marketing Preferences. To learn more about Yahoo!'s use of personal information, including the use of web beacons in HTML-based email, please read our Privacy Policy. Yahoo! is located at 701 First Avenue, Sunnyvale, CA 94089.
\"\"

No comments:

Post a Comment